Is there a relationship between the use of phosphodiesterase type 5 inhibitors and testosterone levels in men?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18875584
Cited by: 0

Abstract

Phosphodiesterase type 5 inhibitors do not consistently affect testosterone levels when used alone, though combination therapies may influence testosterone under certain conditions.

Fields of Study & Subjects

Hormonal and reproductive studies Sexual function and dysfunction studies Phosphodiesterase function and regulation

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
5 March 2026
Language
EN